Endothelin receptor antagonism - improving outcomes in pulmonary arterial hypertension: Munich, 31 August 2004.

T. Oosterhof
Netherlands Heart Journal
Abstract:The first speaker, V. Richard (Rouen, France), presented the rationale behind endothelin receptor antagonism treatment in pulmonary arterial hypertension. Endothelin is a regulatory peptide which is produced by vascular endothelial cells at low levels in healthy individuals. In pulmonary arterial hypertension, endothelin concentration is increased after stimulation of the endothelin system. ET-A receptors (present on smooth muscle cells and fibroblasts) and ET-B receptors (present on smooth muscle cells, fibroblasts, endothelial cells and macrophages) are considered the primary receptors of endothelin. Stimulation of receptors on smooth muscle cells leads to contraction and proliferation, and stimulation of receptors on fibroblasts leads to fibrosis. However, stimulation of ET-B on the endothelium leads to relaxation of the cell, an inflammatory response and a downregulation of endothelin. Due to endothelial dysfunction, synthesis ofendothelin is, however, increased and ET-B receptors are downregulated on endothelial cells and upregulated on smooth muscle cells, which results in increased vasoconstriction and decreased pulmonary clearance. The combined effects ofincreased endothelin concentration include pulmonary vasoconstriction, proliferation of vascular smooth muscle cells, fibrosis (proliferation of fibroblasts and production of extracellular matrix), and inflammation. Furthermore, increased endothelin concentration induces hypertrophy of the cardiac and vascular cells. Pulmonary arterial hypertension is characterised by fibrosis and hypertrophy ofthe pulmonary arterioles, which results in increased pulmonary vascular resistance. In an animal model of chronic overcirculation induced pulmonary arterial hypertension it was suggested that activation of the endothelin system played a major role in pulmonary arterial hypertension initiation. In patients with pulmonary arterial hypertension, overexpression of endothelin has been observed and the degree of overexpression correlated with the degree ofpulmonary vascular resistance. In patients with idiopathic pulmonary arterial hypertension, endothelin levels were related to disease severity and prognosis in these patients. Also, in patients with
What problem does this paper attempt to address?